T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-II α , survivin, and E-cadherin-Reference-Cited by-同舟云学术

T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-II α , survivin, and E-cadherin

Published:2016-11 Issue: Volume:57 Page:78-84
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Raspollini Maria Rosaria,Luque Rafael J.,Menendez Carmen Luz,Bollito Enrico,Brunelli Matteo,Martignoni Guido,Montironi Rodolfo,Cheng Liang,Blanca Ana,Baroni Gianna,Minervini Andrea,Lopez-Beltran Antonio

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference30 articles.

1. Factors affecting recurrence and progression in superficial bladder tumors;Kurth;Eur J Cancer,1995

2. Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy;van Rhijn;Eur Urol,2009

3. A preoperative marker panel for the prediction of residual tumor and the decision making for repeat transurethral resection;Liu;Urol Oncol,2015

4. Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

5. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder, the 2011 update;Babjuk;Eur Urol,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paper electrochemical immunosensor for the rapid screening of Galectin-3 patients with heart failure;Talanta;2024-07

2. CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients;Molecular Therapy: Oncology;2024-06

3. Clinico-Pathological Features and Immunohistochemical Comparison of p16, p53, and Ki-67 Expression in Muscle-Invasive and Non-Muscle-Invasive Conventional Urothelial Bladder Carcinoma;Clinics and Practice;2023-07-09

4. Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer;Frontiers in Oncology;2023-02-10

5. Clinical significance of galectin-3 expression in urinary bladder carcinoma;Journal of International Medical Research;2023-02